Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Mylan Reacts to EpiPen Backlash.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Author(s): Rockoff, Jonathan D.
- Source:
Wall Street Journal (Online). 8/26/2016, p1. 1p.
- Subject Terms:
- Additional Information
- Subject Terms:
- Abstract:
The article reports on the reactions related to the pricing of the EpiPens, an epinephrine autoinjector use to treat allergic reactions offered by pharmaceutical company Mylan NV. Topics discussed include the implication of the drug's price increase to patients and on the market, the criticism of the company's pricing by lawmakers, politicians, and physicians, and the effect of the absence of real competition which allows the company to increase the drug's price.
No Comments.